+96.3%
DINO vs GSK
+9.8%
+86.5%
-24.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.5% | -0.5% | +0.2% |
| 7D | +5.7% | +1.1% | +4.5% | +6.1% |
| 30D | -19.6% | +6.3% | -25.9% | -17.6% |
| 3M | +11.8% | +1.8% | +10.0% | +13.4% |
| 6M | +49.0% | +1.7% | +47.3% | +51.4% |
| YTD | +128.1% | +6.5% | +121.6% | +120.6% |
| 1Y | +96.3% | +9.5% | +86.8% | +90.6% |
| All | +96.3% | +9.8% | +86.5% | +90.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling